Neutral metalloendopeptidase inhibitors in the treatment of hypertension
申请人:SCHERING CORPORATION
公开号:EP0254032A2
公开(公告)日:1988-01-27
The method of treating hypertension with neutral metalloendopeptidase (NMEP) inhibitors, NMEP inhibitors in combination with atrial peptides, and NMEP inhibitors in combination with angiotensin converting enzyme inhibitors, as well as pharmaceutical compositions therefor, are disclosed.